Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
Mar Drugs ; 21(2)2023 Feb 14.
Article in English | MEDLINE | ID: mdl-36827166

ABSTRACT

Oleaginous diatoms accumulate lipids of biotechnological interest when exposed to nutrient stress conditions such as nitrogen starvation. While accumulation mechanisms are well-known and have been engineered to improve lipid production, degradation mechanisms remain poorly investigated in diatoms. Identifying lipid-degrading enzymes is the initial step to understanding the catabolic processes. In this study, an in silico screening of the genome of Phaeodactylum tricornutum led to the identification of 57 putative triacylglycerol lipases (EC 3.1.1.3) grouped in 4 families. Further analysis revealed the presence of conserved domains and catalytic residues of lipases. Physico-chemical characteristics and subcellular localization predictions highlighted that a majority of these putative proteins are hydrophilic and cytosolic, suggesting they could be recruited to lipid droplets directly from the cytosol. Among the 57 identified putative proteins, three lipases were identified as possibly involved in lipophagy due to a potential vacuolar localization. The expression of the mRNA corresponding to the 57 proteins was then searched in 3 transcriptomic datasets obtained under nitrogen starvation. Nine genes were highly regulated and were considered as encoding enzymes with a probable important function in lipid catabolism. A tertiary structure prediction of these nine candidates yielded eight functional 3D models. Among those, two downregulated enzymes, Phatr3_J54974 and Phatr3_EG00720, were highlighted as good targets for future functional genomics and purification studies to investigate their role in lipid degradation.


Subject(s)
Diatoms , Computational Biology , Diatoms/metabolism , Gene Expression Profiling , Lipase/metabolism , Lipids , Nitrogen/metabolism
2.
Molecules ; 27(13)2022 Jun 30.
Article in English | MEDLINE | ID: mdl-35807489

ABSTRACT

Long-chain polyunsaturated fatty acids n-3 series (n-3 LC-PUFAs), especially eicosapentaenoic and docosahexaenoic acids, are known to exert preventive effects on obesity and metabolic syndrome. Mainly consumed in the form of fish oil, LC-PUFAs n-3 are also found in significant quantities in other sources such as certain microalgae. The aim of this study was to evaluate the effects of Diacronema lutheri (Dia), a microalga rich in n-3 LC-PUFAs, on metabolic disorders associated with obesity. Three groups of male Wistar rats (n = 6 per group) were submitted for eight weeks to a standard diet or high-fat and high-fructose diet (HF), supplemented or not with 12% of Dia (HF-Dia). Compared to HF rats, HF-Dia rats showed a 41% decrease in plasma triacylglycerol (TAG) and an increase in plasma cholesterol (+35%) as well as in high-density lipoprotein cholesterol (+51%) without change to low-density lipoprotein cholesterol levels. Although fasting glycemia did not change, glucose and insulin tolerance tests highlighted an improvement in glucose and insulin homeostasis. Dia supplementation restored body weight and fat mass, and decreased levels of liver TAG (-75%) and cholesterol (-84%). In HF-Dia rats, leptin was decreased (-30%) below the control level corresponding to a reduction of 68% compared to HF rats. Similarly, the anti-inflammatory cytokines interleukin-4 (IL-4) and IL-10 were restored up to control levels, corresponding to a 74% and 58% increase in HF rats, respectively. In contrast, the level of IL-6 remained similar in the HF and HF-Dia groups and about twice that of the control. In conclusion, these results indicated that the D. lutheri microalga may be beneficial for the prevention of weight gain and improvement in lipid and glucose homeostasis.


Subject(s)
Fatty Acids, Omega-3 , Metabolic Syndrome , Microalgae , Animals , Diet, High-Fat/adverse effects , Fatty Acids , Fatty Acids, Omega-3/pharmacology , Fructose , Glucose , Insulin , Male , Metabolic Syndrome/complications , Metabolic Syndrome/prevention & control , Obesity/metabolism , Rats , Rats, Wistar , Triglycerides
3.
Mar Drugs ; 18(1)2019 Dec 18.
Article in English | MEDLINE | ID: mdl-31861403

ABSTRACT

Marine microalgae are known to be a source of bioactive molecules of interest to human health, such as n-3 polyunsaturated fatty acids (n-3 PUFAs) and carotenoids. The fact that some of these natural compounds are known to exhibit anti-inflammatory, antioxidant, anti-proliferative, and apoptosis-inducing effects, demonstrates their potential use in preventing cancers and cardiovascular diseases (CVDs). Benzo[a]pyrene (B[a]P), a polycyclic aromatic hydrocarbon (PAH), is an ubiquitous environmental pollutant known to contribute to the development or aggravation of human diseases, such as cancer, CVDs, and immune dysfunction. Most of these deleterious effects are related to the activation of the polycyclic aromatic hydrocarbon receptor (AhR). In this context, two ethanolic microalgal extracts with concentrations of 0.1 to 5 µg/mL are tested, Ostreoccoccus tauri (OT) and Phaeodactylum tricornutum (PT), in order to evaluate and compare their potential effects towards B[a]P-induced toxicity in endothelial HMEC-1 cells. Our results indicate that the OT extract can influence the toxicity of B[a]P. Indeed, apoptosis and the production of extracellular vesicles were decreased, likely through the reduction of the expression of CYP1A1, a B[a]P bioactivation enzyme. Furthermore, the B[a]P-induced expression of the inflammatory cytokines IL-8 and IL1-ß was reduced. The PT extract only inhibited the expression of the B[a]P-induced cytokine IL-8 expression. The OT extract therefore seems to be a good candidate for counteracting the B[a]P toxicity.


Subject(s)
Benzo(a)pyrene/toxicity , Biological Products/pharmacology , Microalgae/chemistry , Apoptosis/drug effects , Cell Line , Cell Survival/drug effects , Cytochrome P-450 CYP1A1/metabolism , Cytokines/drug effects , Endothelial Cells , Extracellular Vesicles/drug effects , Extracellular Vesicles/ultrastructure , Humans , Oceans and Seas
4.
Bioresour Technol ; 394: 130274, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38160848

ABSTRACT

Marine diatoms have high adaptability and are known to accumulate lipids under nutrient stress conditions. The present study involves determining the effect of varying macro and micronutrients on growth kinetics and metabolite production of oleaginous marine diatoms, Thalassiosira weissflogii and Chaetoceros gracilis. The results highlighted that C. gracilis and T. weissflogii showed maximum biomass yield of 0.86 ± 0.06 g/L and 0.76 ± 0.01 g/L in the 2f and f supplemented medium respectively. A 2.5-fold increase in cellular lipid content was recorded in the 2f culture setup of both strains ranging from 20 % to 26.7 % (w/w). The study also reveals that high eutrophic nutrient media (f, 2f and 4f) triggered biomass productivity as well as total protein and carbohydrate content in both strains. Thus, providing a reproducible insight of trophic flexibility of diatoms, concomitant with the increment in multiple commercially valuable products.


Subject(s)
Diatoms , Diatoms/metabolism , Biomass , Nutrients
5.
Lipids Health Dis ; 12: 107, 2013 Jul 20.
Article in English | MEDLINE | ID: mdl-23870174

ABSTRACT

BACKGROUND: It is now established that patients with hyperlipidemia have a high risk of atherosclerosis and thrombotic complications, which are two important events responsible for the onset and progression of cardiovascular disease. In the context of managing dyslipidemia by means of dietary advice based on the consumption of argan oil, we wanted to investigate the effect of virgin argan oil on plasma lipids, and for the first time, on the platelet hyperactivation and oxidative status associated with dyslipidemia. This study concerns patients recruited in the area of Rabat in Morocco. METHODS: 39 dyslipidemic (79% women) patients were recruited for our study in the area of Rabat in Morocco. They were randomly assigned to the two following groups: the argan group, in which the subjects consumed 25 mL/day of argan oil at breakfast for 3 weeks, and the control group in which argan oil was replaced by butter. RESULTS: After a 3-week consumption period, blood total cholesterol was significantly lower in the argan oil group, as was LDL cholesterol (23.8% and 25.6% lower, respectively). However, the HDL cholesterol level had increased by 26% at the end of the intervention period compared to baseline. Interestingly, in the argan oil group thrombin-induced platelet aggregation was lower, and oxidative status was enhanced as a result of lower platelet MDA and higher GPx activity, respectively. CONCLUSIONS: In conclusion, our results, even if it is not representative of the Moroccan population, show that argan oil can prevent the prothrombotic complications associated with dyslipidemia, which are a major risk factor for cardiovascular disease.


Subject(s)
Dyslipidemias/blood , Dyslipidemias/drug therapy , Lipids/blood , Oxidative Stress/drug effects , Plant Oils/administration & dosage , Adult , Atherosclerosis/complications , Atherosclerosis/drug therapy , Atherosclerosis/pathology , Cholesterol/blood , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Dyslipidemias/complications , Dyslipidemias/pathology , Female , Humans , Male , Middle Aged , Morocco , Platelet Aggregation/drug effects , Sapotaceae/chemistry , Thrombosis/complications , Thrombosis/drug therapy , Thrombosis/pathology
6.
Mar Drugs ; 11(9): 3425-71, 2013 Sep 09.
Article in English | MEDLINE | ID: mdl-24022731

ABSTRACT

Phytoplankton is acknowledged to be a very diverse source of bioactive molecules. These compounds play physiological roles that allow cells to deal with changes of the environmental constrains. For example, the diversity of light harvesting pigments allows efficient photosynthesis at different depths in the seawater column. Identically, lipid composition of cell membranes can vary according to environmental factors. This, together with the heterogenous evolutionary origin of taxa, makes the chemical diversity of phytoplankton compounds much larger than in terrestrial plants. This contribution is dedicated to pigments and lipids synthesized within or from plastids/photosynthetic membranes. It starts with a short review of cyanobacteria and microalgae phylogeny. Then the bioactivity of pigments and lipids (anti-oxidant, anti-inflammatory, anti-mutagenic, anti-cancer, anti-obesity, anti-allergic activities, and cardio- neuro-, hepato- and photoprotective effects), alone or in combination, is detailed. To increase the cellular production of bioactive compounds, specific culture conditions may be applied (e.g., high light intensity, nitrogen starvation). Regardless of the progress made in blue biotechnologies, the production of bioactive compounds is still limited. However, some examples of large scale production are given, and perspectives are suggested in the final section.


Subject(s)
Biological Products/metabolism , Lipids/biosynthesis , Phytoplankton/metabolism , Pigments, Biological/metabolism , Plastids/metabolism , Seawater/microbiology , Animals , Cyanobacteria/metabolism , Humans , Photosynthesis/physiology
7.
Antioxidants (Basel) ; 12(5)2023 May 05.
Article in English | MEDLINE | ID: mdl-37237915

ABSTRACT

In recent years, microalgae have become a source of molecules for a healthy life. Their composition of carbohydrates, peptides, lipids, vitamins and carotenoids makes them a promising new source of antioxidant molecules. Skeletal muscle is a tissue that requires constant remodeling via protein turnover, and its regular functioning consumes energy in the form of adenosine triphosphate (ATP), which is produced by mitochondria. Under conditions of traumatic exercise or muscular diseases, a high production of reactive oxygen species (ROS) at the origin of oxidative stress (OS) will lead to inflammation and muscle atrophy, with life-long consequences. In this review, we describe the potential antioxidant effects of microalgae and their biomolecules on mitochondrial functions and skeletal muscular oxidative stress during exercises or in musculoskeletal diseases, as in sarcopenia, chronic obstructive pulmonary disease (COPD) and Duchenne muscular dystrophy (DMD), through the increase in and regulation of antioxidant pathways and protein synthesis.

8.
Nutrients ; 15(9)2023 Apr 29.
Article in English | MEDLINE | ID: mdl-37432249

ABSTRACT

Docosahexaenoic acid (DHA, C22:6 ω-3) is a dietary polyunsaturated fatty acid that has an important role in human health. Epidemiological studies linked a high intake of DHA to a reduced risk of certain cancers. Recently, attention focused on how the lipid carrier in which DHA is delivered, i.e., esterified on acylglycerols, phospholipids, or free, affects its biological effects. However, studies comparing the effects of these different forms for DHA supply to cancer cells in vitro are limited. In this study, the effect of free DHA and five lipids carrying one to three DHA chains (LPC-DHA, PC-DHA, MAG-DHA, DAG-DHA and TAG-DHA) on the viability of the MDA-MB-231 breast cancer cell line was compared. Our results revealed a strong structure-function relationship of DHA-carrying lipids on the viability of MDA-MB-231 cells. Glycerophosphocholine-based lipids are the most effective DHA carriers in reducing the viability of MDA-MB-231 cells, with LPC-DHA being more effective (IC50 = 23.7 µM) than PC-DHA (IC50 = 67 µM). The other tested lipids are less toxic (MAG-DHA, free DHA) or even not toxic (DAG-DHA, TAG-DHA) under our conditions. Investigating the mechanism of cell death induced by LPC-DHA revealed increased oxidative stress and membrane cell damage.


Subject(s)
Antineoplastic Agents , Breast Neoplasms , Humans , Female , Lysophosphatidylcholines/pharmacology , Docosahexaenoic Acids/pharmacology , Fatty Acids , MDA-MB-231 Cells
9.
Front Plant Sci ; 14: 1257500, 2023.
Article in English | MEDLINE | ID: mdl-37810403

ABSTRACT

Introduction: Phaeodactylum tricornutum is a model species frequently used to study lipid metabolism in diatoms. When exposed to a nutrient limitation or starvation, diatoms are known to accumulate neutral lipids in cytoplasmic lipid droplets (LDs). Those lipids are produced partly de novo and partly from the recycle of plastid membrane lipids. Under a nitrogen resupply, the accumulated lipids are catabolized, a phenomenon about which only a few data are available. Various strains of P. tricornutum have been isolated around the world that may differ in lipid accumulation patterns. Methods: To get further information on this topic, two genetically distant ecotypes of P. tricornutum (Pt1 and Pt4) have been cultivated under nitrogen deprivation during 11 days followed by a resupply period of 3 days. The importance of cytoplasmic LDs relative to the plastid was assessed by a combination of confocal laser scanning microscopy and cell volume estimation using bright field microscopy pictures. Results and discussion: We observed that in addition to a basal population of small LDs (0.005 µm3 to 0.7 µm3) present in both strains all along the experiment, Pt4 cells immediately produced two large LDs (up to 12 µm3 after 11 days) while Pt1 cells progressively produced a higher number of smaller LDs (up to 7 µm3 after 11 days). In this work we showed that, in addition to intracellular available space, lipid accumulation may be limited by the pre-starvation size of the plastid as a source of membrane lipids to be recycled. After resupplying nitrogen and for both ecotypes, a fragmentation of the largest LDs was observed as well as a possible migration of LDs to the vacuoles that would suggest an autophagic degradation. Altogether, our results deepen the understanding of LDs dynamics and open research avenues for a better knowledge of lipid degradation in diatoms.

10.
Lipids Health Dis ; 11: 147, 2012 Oct 31.
Article in English | MEDLINE | ID: mdl-23110391

ABSTRACT

BACKGROUND: Dietary changes are a major factor in determining cardiovascular risk. n-3 polyunsaturated fatty acids modulate the risk factors for metabolic syndrome via multiple mechanisms, including the regulation of the lipid metabolism. We therefore investigated the effect of Odontella aurita, a microalga rich in EPA, which is already used as a food supplement, on the risk factors for high-fat diet induced metabolic syndrome in rats. METHODS: Male Wistar rats were divided into 4 groups and were fed with a standard diet (control); with the standard diet supplemented with 3% freeze-dried O. aurita (COA); with a high-fat diet (HF); or with the high-fat diet supplemented with 3% of freeze-dried O. aurita (HFOA) for 7 weeks. In this study we evaluated the impact of these different diets on the risk factors for metabolic syndrome, such as hyperlipidemia, platelet aggregation, thromboxane B2 production, and oxidative stress. RESULTS: After 7 weeks of treatment, high fat feeding had increased final body weight, glycemia, triacylglycerol, and total cholesterol levels in plasma and liver compared to the control diet. Collagen-induced platelet aggregation and basal platelet thromboxane B2 were also higher in the high-fat fed rats than in those in the control group. In the liver, oxidative stress was greater in the HF group than in the control group. O. aurita intake in HFOA-fed rats resulted in lower glycemia and lipid levels in the plasma and liver relative than in the HF group. Thus, in the HFOA group, n-3 polyunsaturated fatty acid levels in the tissues studied (plasma, liver, and platelets) were higher than in the HF group. Platelet hyper-aggregability tended to decrease in HFOA-fed rats as basal platelet thromboxane B2 production decreased. Finally, O. aurita reduced oxidative stress in the liver, with lower malondialdehyde levels and increased glutathione peroxidase activity. CONCLUSIONS: O. aurita is a marine diatom rich in EPA as well as in other bioactive molecules, such as pigments. The synergistic effect of these microalgal compounds, displayed a beneficial effect in reducing the risk factors for high-fat induced metabolic syndrome: hyperlipidemia, platelet aggregation, and oxidative stress.


Subject(s)
Diatoms/chemistry , Dietary Fats/administration & dosage , Dietary Supplements , Dyslipidemias/diet therapy , Animals , Aquatic Organisms/chemistry , Blood Platelets/metabolism , Diet, High-Fat , Dietary Fats/metabolism , Dyslipidemias/blood , Dyslipidemias/metabolism , Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Omega-3/metabolism , Fatty Acids, Unsaturated/administration & dosage , Fatty Acids, Unsaturated/metabolism , Lipid Metabolism/drug effects , Male , Oxidative Stress/drug effects , Rats , Rats, Wistar , Triglycerides/blood , Weight Gain/drug effects
11.
Article in English | MEDLINE | ID: mdl-35805595

ABSTRACT

Nowadays, diet and breast cancer are studied at different levels, particularly in tumor prevention and progression. Thus, the molecular mechanisms leading to better knowledge are deciphered with a higher precision. Among the molecules implicated in a preventive and anti-progressive way, n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFAs) are good candidates. These molecules, like docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids, are generally found in marine material, such as fat fishes or microalgae. EPA and DHA act as anti-proliferative, anti-invasive, and anti-angiogenic molecules in breast cancer cell lines, as well as in in vivo studies. A better characterization of the cellular and molecular pathways involving the action of these fatty acids is essential to have a realistic image of the therapeutic avenues envisaged behind their use. This need is reinforced by the increase in the number of clinical trials involving more and more n-3 LC-PUFAs, and this, in various pathologies ranging from obesity to a multitude of cancers. The objective of this review is, therefore, to highlight the new elements showing the preventive and beneficial effects of n-3 LC-PUFAs against the development and progression of breast cancer.


Subject(s)
Breast Neoplasms , Fatty Acids, Omega-3 , Breast Neoplasms/drug therapy , Breast Neoplasms/prevention & control , Docosahexaenoic Acids/metabolism , Eicosapentaenoic Acid/pharmacology , Eicosapentaenoic Acid/therapeutic use , Fatty Acids , Fatty Acids, Omega-3/therapeutic use , Female , Humans , Risk Factors
12.
Nutrients ; 13(2)2021 Jan 28.
Article in English | MEDLINE | ID: mdl-33525643

ABSTRACT

Long-chain polyunsaturated fatty acids n-3 series and especially docosahexaenoic acid are known to exert preventive effects on metabolic disturbances associated with obesity and decrease cardiovascular disease risk. n-3 LC-PUFAs are mainly consumed in the form of fish oil, while other sources, such as certain microalgae, may contain a high content of these fatty acids. The aim of this study was to evaluate the effects of Tisochrysis lutea (Tiso), a microalga rich in DHA, on metabolic disorders associated with obesity. Three male Wistar rat groups were submitted for eight weeks to a standard diet or high-fat and high fructose diet (HF), supplemented or not with 12% of T. lutea (HF-Tiso). The supplementation did not affect plasma alanine aminotransferase (ALAT). Bodyweight, glycemia and insulinemia decreased in HF-Tiso rats (ANOVA, p < 0.001), while total plasma cholesterol, high-density lipoprotein-cholesterol (HDL-C) increased (ANOVA, p < 0.001) without change of low-density lipoprotein-cholesterol (LDL-C) and triacylglycerol (TAG) levels. Tiso supplementation decreased fat mass and leptinemia as well as liver TAG, cholesterol and plasma tumor necrosis factor-alpha levels (ANOVA, p < 0.001) while it did not affect interleukin 6 (IL-6), IL-4 and lipopolysaccharides levels. HF-Tiso rats showed an increase of IL-10 level in abdominal adipose tissue (ANOVA, p < 0.001). In conclusion, these results indicated that DHA-rich T. lutea might be beneficial for the prevention of obesity and improvement of lipid and glucose metabolism.


Subject(s)
Aquatic Organisms/chemistry , Metabolic Syndrome/prevention & control , Microalgae/chemistry , Obesity/prevention & control , Adiposity , Animals , Body Weight , Cytokines/blood , Diet, High-Fat , Dietary Supplements , Drinking Behavior , Energy Intake , Feeding Behavior , Inflammation Mediators/blood , Insulin Resistance , Lipids/blood , Lipopolysaccharides/blood , Liver/metabolism , Male , Metabolic Syndrome/blood , Obesity/blood , Rats, Wistar
13.
Biochimie ; 167: 106-118, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31545993

ABSTRACT

Microalgae are photosynthetic microorganisms that produce numerous bioactive molecules that can be used as food supplement to prevent chronic disease installation. Indeed, they produce phycobiliproteins, polysaccharides, lipids, carotenoids and sterolic compounds. The use of microalgae in human nutrition provide a mixture of these molecules with synergistic effect. The aim of this review is to present the specific roles played by the xanthophylls, and specifically astaxanthin and fucoxanthin, two high added value carotenoids, and by microalgal phytosterols such as ß-sitosterol, campesterol and stigmasterol on several cell mechanisms involved in the prevention of cardiometabolic diseases and cancers. This review explains how these microalgal molecules modulate cell signaling pathways involved in carbohydrate and lipid metabolisms, inflammation, apoptosis, invasion and metastasis. Xanthophylls and phytosterols are involved in the reduction of inflammatory markers in relation with the regulation of the c-Jun N-terminal kinases and nuclear factor-kappa B signaling pathways, and suppression of production of pro-inflammatory mediators. Xanthophylls act on glucose and lipid metabolisms via both the upregulation of peroxisome proliferator-activated receptors (PPARs) and glucose transporters and its effects on the expression of enzymes involved in fatty acid synthesis and cholesterol metabolism. Their anti-cancer effects are related to the induction of intrinsic apoptosis due to down-regulation of key regulatory kinases. The anti-angiogenesis, anti-proliferative and anti-invasive effects are correlated with decreased production of endothelial growth factors and of matrix metalloproteinases. Phytosterols have a major role on cholesterol absorption via modification of the activities of Niemann-Pick C1 like 1 and ATP-binding cassette transporters and on cholesterol esterification. Their action are also related with the modulation of PPARs and sterol regulatory element-binding protein-1 activities.


Subject(s)
Cholesterol/analogs & derivatives , Phytosterols/pharmacology , Sitosterols/pharmacology , Xanthophylls/pharmacology , Apoptosis/drug effects , Carbohydrate Metabolism/drug effects , Cardiovascular Diseases/prevention & control , Cholesterol/pharmacology , Dietary Supplements , Humans , Lipid Metabolism/drug effects , Metabolic Diseases/prevention & control , Microalgae/metabolism , Neoplasms/prevention & control , Signal Transduction
14.
Nutrients ; 11(5)2019 May 14.
Article in English | MEDLINE | ID: mdl-31091691

ABSTRACT

Long-chain polyunsaturated fatty acids, n-3 series (n-3 LC-PUFA), are known for their preventive effects against cardiovascular disease. In an unfavourable economic and environmental context of fish oil production, marine microalgae could be an alternative source of n-3 LC-PUFA and are of interest for human nutrition. The aim of this study was to evaluate the effects of P. tricornutum, a microalga rich in eicosapentaenoic acid and used as a food supplement, on the metabolic disorders associated with metabolic syndrome and obesity development. Three male Wistar rat groups (n = 6) were submitted for eight weeks to a standard diet or high-fat diet (HF) with 10% fructose in drinking water, supplemented or not with 12% of P. tricornutum (HF-Phaeo). Supplementation led to n-3 LC-PUFA enrichment of lipids in the liver, plasma and erythrocytes. Plasma transaminases showed no difference between the HF and HF-Phaeo groups. Body weight, fat mass, inflammatory markers and insulinemia decreased in HF-Phaeo rats versus the HF group. Plasma total cholesterol, triacylglycerols and leptine diminished in HF-Phaeo rats, while HDL-cholesterol increased. In conclusion, this study highlights the beneficial effects of P. tricornutum in reducing the metabolic disorders associated with metabolic syndrome.


Subject(s)
Dietary Supplements , Metabolic Syndrome/prevention & control , Microalgae , Animal Feed/analysis , Animals , Body Weight , Diet/veterinary , Diet, High-Fat , Fatty Acids, Unsaturated/chemistry , Fatty Acids, Unsaturated/pharmacology , Male , Metabolic Syndrome/diet therapy , Rats , Rats, Wistar , Risk Factors
15.
Nutrition ; 57: 32-39, 2019 01.
Article in English | MEDLINE | ID: mdl-30153577

ABSTRACT

OBJECTIVES: The aim of this study was to investigate the effects of two different sources of polyunsaturated fatty acid-fish oil (FO) and argan oil (AO)-on some risk factors for cardiovascular disease, such as platelet aggregation, dyslipidemia, and oxidative stress. METHODS: To explore this, four groups of six male rats were fed with different diets: The first group received a standard diet (control); the second group received a high-fat diet; the third was fed with a high-fat diet supplemented with 5% FO, and the last group received a high-fat diet supplemented with 5% AO. RESULTS: After 8 wk of the diet, AO showed a decrease in plasma lipids similar to that of FO. However, unlike FO, AO had no significant effect on hepatic lipid levels. On the other hand, supplementation with AO and FO similarly reduced platelet hyperactivity induced by high-fat diet. Concerning the results of oxidative stress, AO showed an antioxidant effect in the tissues and platelets greater than that observed in the high-fat FO group. CONCLUSIONS: For rats, the consumption of FO prevented the development of adiposity, restored insulin sensitivity, decreased plasma and liver lipid levels, and also prevented the prothrombotic effect. Intake of AO as a food supplement did not affect adiposity or liver lipid levels but decreased plasma lipid levels and improved oxidative status and platelet activity. FO and, to a lesser degree, AO thus represent promising nutritional tools in the prevention of cardiovascular disease.


Subject(s)
Cardiovascular Diseases/prevention & control , Diet, High-Fat/adverse effects , Dietary Supplements , Fish Oils/pharmacology , Lipids/blood , Plant Oils/pharmacology , Adiposity/drug effects , Animals , Cardiovascular Diseases/blood , Cardiovascular Diseases/etiology , Disease Models, Animal , Fish Oils/blood , Male , Mice , Rats , Rats, Wistar , Risk Factors
16.
Environ Pollut ; 255(Pt 1): 113171, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31539851

ABSTRACT

Environmental contaminants, to which humans are widely exposed, cause or worsen several diseases, like cardiovascular diseases and cancers. Among these molecules, polycyclic aromatic hydrocarbons (PAHs) stand out since they are ubiquitous pollutants found in ambient air and diet. Because of their toxic effects, public Health agencies promote development of research studies aiming at increasing the knowledge about PAHs and the discovery of biomarkers of exposure and/or effects. Extracellular vesicles (EVs), including small extracellular vesicles (S-EVs or exosomes) and large extracellular vesicles (L-EVs or microvesicles), are delivery systems for multimolecular messages related to the nature and status of the originating cells. Because they are produced by all cells and detected within body fluids, EV releases could act as cell responses and thereby serve as biomarkers. To test whether EVs can serve as biomarkers of PAHs exposure, we evaluate the effects of these pollutants on EV production using an in vitro approach (human endothelial cell line, HMEC-1) and an in vivo approach (urine samples from PAHs-exposed rats). Our study indicates that, i) PAH exposure increases in vitro the EV production by endothelial cells and in vivo the release of EVs in urine, and that the stimulating effects of PAHs concern both S-EVs and L-EVs; ii) PAH exposure and more particularly exposure to B[a]P, can influence the composition of exosomes produced by endothelial cells; iii) the aryl hydrocarbon receptor, a cytosolic receptor associated to most deleterious effects of PAHs, would be involved in the PAH effects on the release of S-EVs, but not L-EVs. These results suggest that EVs may have utility for monitoring exposure to PAHs, and more particularly to B[a]P, considered as reference PAH, and to detect the related early cellular response prior to end-organ damages.


Subject(s)
Endothelial Cells/metabolism , Environmental Pollutants/toxicity , Extracellular Vesicles/metabolism , Polycyclic Aromatic Hydrocarbons/toxicity , Urine/chemistry , Animals , Biomarkers/metabolism , Body Fluids/chemistry , Cell Line , Environmental Exposure/adverse effects , Environmental Monitoring/methods , Exosomes , Female , Humans , Rats , Receptors, Aryl Hydrocarbon/metabolism
17.
Philos Trans R Soc Lond B Biol Sci ; 372(1728)2017 Sep 05.
Article in English | MEDLINE | ID: mdl-28717017

ABSTRACT

Diatoms are responsible for up to 40% of the carbon fixation in our oceans. The fixed carbon is moved through carbon metabolism towards the synthesis of organic molecules that are consumed through interlocking foodwebs, and this process is strongly impacted by the abiotic environment. However, it has become evident that diatoms can be used as 'platform' organisms for the production of high valuable bio-products such as lipids, pigments and carbohydrates where stress conditions can be used to direct carbon metabolism towards the commercial production of these compounds. In the first section of this review, some aspects of carbon metabolism in diatoms and how it is impacted by environmental factors are briefly described. The second section is focused on the biosynthesis of lipids and in particular omega-3 long-chain polyunsaturated fatty acids and how low temperature stress impacts on the production of these compounds. In a third section, we review the recent advances in bioengineering for lipid production. Finally, we discuss new perspectives for designing strains for the sustainable production of high-value lipids.This article is part of the themed issue 'The peculiar carbon metabolism in diatoms'.


Subject(s)
Carbon/metabolism , Cold Temperature , Diatoms/metabolism , Lipids/biosynthesis , Bioengineering , Lipid Metabolism , Stress, Physiological
18.
Mini Rev Med Chem ; 17(12): 1112-1123, 2017.
Article in English | MEDLINE | ID: mdl-27457215

ABSTRACT

BACKGROUND: The fatty acids of seed plants and microalgae stored in triglyceride are all produced in the plastid and incorporated into triglycerides by a complex biochemical exchange between the plastid envelope and the endoplasmic reticulum. The oils of seed plants provide the basis for vegetal fat production and the microalgal fats represent an important part of the basal food web of the marine environment. The health-promoting properties of these various sources of fats and in particular the long-chain polyunsaturated fatty acids of marine microalgae are widely recognized. The omega-3 fatty acids are known to have benefits on health and disease. Indeed, alpha-linolenic, eicosapentaenoic (EPA) and docosahexaenoic acids (DHA) are linked to the regulation of mechanisms involved in numerous biological functions associated with cardiovascular disease and cancer prevention. Most EPA and DHA sources for human nutrition are provided by decreasing global stocks of fish. This is one of the reasons why industrial research has been directed towards more sustainable sources of these "marine" lipids. The synthesis of fatty acids and triglycerides are in many respects similar in higher plants and marine algae, but there are also important differences. CONCLUSION: This mini-review covers the biochemistry of fatty acid and lipid synthesis in marine microalgae, and the potential health impact of the different fats is also discussed.


Subject(s)
Fatty Acids, Omega-3/metabolism , Microalgae/metabolism , Anticholesteremic Agents/chemistry , Anticholesteremic Agents/metabolism , Anticholesteremic Agents/therapeutic use , Cardiovascular Diseases/metabolism , Cardiovascular Diseases/pathology , Cardiovascular Diseases/prevention & control , Docosahexaenoic Acids/chemistry , Docosahexaenoic Acids/metabolism , Docosahexaenoic Acids/therapeutic use , Eicosapentaenoic Acid/chemistry , Eicosapentaenoic Acid/metabolism , Eicosapentaenoic Acid/therapeutic use , Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Omega-3/therapeutic use , Fatty Acids, Unsaturated/chemistry , Fatty Acids, Unsaturated/metabolism , Fatty Acids, Unsaturated/therapeutic use , Humans , Neoplasms/metabolism , Neoplasms/pathology , Neoplasms/prevention & control , Triglycerides/blood
19.
Lipids ; 51(9): 1037-49, 2016 09.
Article in English | MEDLINE | ID: mdl-27503614

ABSTRACT

Dietary supplementation with marine omega-3 polyunsaturated fatty acids (n-3 PUFA) can have beneficial effects on a number of risk factors for cardiovascular disease (CVD). We compared the effects of two n-3 PUFA rich food supplements (freeze-dried Odontella aurita and fish oil) on risk factors for CVD. Male rats were randomly divided into four groups of six animals each and fed with the following diets: control group (C) received a standard diet containing 7 % lipids; second group (HF high fat) was fed with a high-fat diet containing 40 % lipids; third group (HFFO high fat+fish oil) was fed with the high-fat diet supplemented with 0.5 % fish oil; and fourth group (HFOA high fat+O. aurita) received the high-fat diet supplemented with 12 % of freeze-dried O. aurita. After 8 weeks rats fed with the high-fat diet supplemented with O. aurita displayed a significantly lower bodyweight than those in the other groups. Both the microalga and the fish oil significantly reduced insulinemia and serum lipid levels. O. aurita was more effective than the fish oil in reducing hepatic triacyglycerol levels and in preventing high-fat diet-induced steatosis. O. aurita and fish oil also reduced platelet aggregation and oxidative status induced by high fat intake. After an OA supplementation, the adipocytes in the HFOA group were smaller than those in the HF group. Freeze-dried O. aurita showed similar or even greater biological effects than the fish oil. This could be explained by a potential effect of the n-3 PUFA but also other bioactive compounds of the microalgae.


Subject(s)
Cardiovascular Diseases/prevention & control , Fatty Acids, Omega-3/administration & dosage , Fatty Liver/prevention & control , Fish Oils/chemistry , Microalgae/chemistry , Animals , Body Weight/drug effects , Diet, High-Fat/adverse effects , Dietary Supplements , Disease Models, Animal , Fatty Acids, Omega-3/pharmacology , Fatty Liver/chemically induced , Lipids/blood , Male , Oxidative Stress/drug effects , Random Allocation , Rats , Treatment Outcome
20.
J Agric Food Chem ; 63(4): 1261-1267, 2015 Feb 04.
Article in English | MEDLINE | ID: mdl-25592433

ABSTRACT

The microalga Pavlova lutheri is a candidate for the production of omega-3 long-chain polyunsaturated fatty acid (LC-PUFA), due to its ability to accumulate both eicosapentaenoic (EPA) and docosahexaenoic acids. Outstanding questions need to be solved to understand the complexity of n-3 LC-PUFA synthesis and partitioning into lipids, especially its metabolic regulation, and which enzymes and/or abiotic factors control their biosynthesis. In this study, the radioactivity of 14C-labeled arachidonic acid incorporated into the total lipids of P. lutheri grown under different light intensities and its conversion into labeled LC-PUFA were monitored. The results highlighted for the first time the light-dependent incorporation of LC-PUFA into lipids and the light-dependent activity of the final desaturation and elongation steps required to synthesize and accumulate n-3 C20/C22 LC-PUFA. The incorporation of arachidonic acid into lipids under low light and the related Δ17-desaturation activity measured explain the variations in fatty acid profile of P. lutheri, especially the accumulation of n-3 LC-PUFA such as EPA under low light conditions.

SELECTION OF CITATIONS
SEARCH DETAIL